News

May 27, 2025

Sleep aid blocks neurodegeneration in mice

Lemborexant, similar sleep drugs show promise in treating disorders related to tau, such as Alzheimer’s disease.

News Release

March 7, 2025

$4.5 million supports pathbreaking neuroimmunology research

Grant funds WashU Medicine’s pursuit of new treatments for Alzheimer’s disease.

News Release

June 5, 2024

Holtzman, Chen recognized for exceptional Alzheimer’s research

Morby prize from Cure Alzheimer’s Fund honors discovery of T cells’ role in neurodegeneration.

National Leaders

April 3, 2024

Immunotherapy for Alzheimer’s disease shows promise in mouse study

Antibody mobilizes immune cells to clear amyloid plaques, reducing behavioral abnormalities.

News Release

December 11, 2023

Clues to preventing Alzheimer’s come from patient who, despite genetics, evaded disease

Breaking link between early, late stages of disease may prevent dementia.

News Release

November 22, 2023

Lowering a form of brain cholesterol reduces Alzheimer’s-like damage in mice

Targeting cholesterol potentially could help treat Alzheimer’s, related dementias.

News Release

March 10, 2023

A scientific grand slam

WashU Med researchers publish in NEJM, JAMA, Nature, Science – all in a week’s time.

Medical Campus & Community

March 8, 2023

Discovery of T cells’ role in Alzheimer’s, related diseases, suggests new treatment strategy

Findings, in mice, open up drug development possibilities for brain diseases linked to tau protein.

News Release

January 12, 2023

Gut bacteria affect brain health, mouse study shows

Findings suggest new approach to treating Alzheimer’s, other neurodegenerative diseases.

News Release

December 14, 2022

WashU, Eisai form drug discovery collaboration

Focus is on therapies for Alzheimer’s, other neurodegenerative diseases.

News Release

August 24, 2022

Diversity, equity, inclusion a pillar of Neuroscience Research Building

‘We are all doing important work’.

Medical Campus & Community